NVIDIA Corporation (NVDA.US) accelerates computing for the next generation of semiconductor factory construction sponsored by Taiwan Semiconductor Manufacturing Co., Ltd. (TSM.US), while Foxconn Medical AI enters clinical operations.

NVIDIA Corporation (NVDA.US) announced on Monday that Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR (TSM.US) is using its accelerated computing and AI technology to advance innovation in semiconductor design and manufacturing processes. NVIDIA Corporation's CUDA-X libraries and AI models are providing computational acceleration for all-scenario workloads such as photolithography, transistor and process simulation, advanced process control, and wafer factory operations for Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR. According to an official statement from NVIDIA Corporation, Taiwan Semiconductor Manufacturing Co., Ltd. Sponsored ADR is leveraging NVIDIA Corporation's Metropolis platform and TAO toolkit to develop an automated defect detection solution based on visual AI. This solution not only improves the accuracy of detecting nanometer-level defects but also reduces the cost of repetitive labeling and model retraining. Furthermore, NVIDIA Corporation stated that Foxconn is deploying its AI technology in medical institutions in Taiwan to advance application models from single AI tools to collaborative AI agent workflows, providing support for clinical diagnosis, medical documentation writing, and healthcare process coordination for healthcare professionals. In another separate statement, Foxconn's CoDoctor AI platform, equipped with a new AI intelligent body, and Nurabot nursing collaboration Siasun Robot&Automation, supported by NVIDIA Corporation's Nemo Claw technology, have officially entered the clinical operational phase from the pilot project stage.